Mesoblast received FDA approval for a specific product on June 1st, led by CEO Silviu Itescu.
2 reports, 2 independent
Updated Nov 6
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Mesoblast received FDA approval for a specific product on June 1st, led by CEO Silviu Itescu.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.FDA approved Mesoblast's cell therapy; William Burns joins the board.1 source
Mesoblast received FDA approval for a specific product on June 1st.1 source
Keep exploring
The entities involved
-
Mesoblast
pharmaceutical company
Nothing else this week.
-
Silviu Itescu
researcher
Nothing else this week.
- FDA